Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD.

MLA

Taskinen, Marja-Riitta, et al. “Emerging Evidence That ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD.” Current Atherosclerosis Reports, vol. 21, no. 8, Aug. 2019, pp. 1–10. EBSCOhost, https://doi.org/10.1007/s11883-019-0791-9.

APA

Taskinen, M.-R., Packard, C. J., & Borén, J. (2019). Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD. Current Atherosclerosis Reports, 21(8), 1–10. https://doi.org/10.1007/s11883-019-0791-9

Chicago

Taskinen, Marja-Riitta, Chris J. Packard, and Jan Borén. 2019. “Emerging Evidence That ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD.” Current Atherosclerosis Reports 21 (8): 1–10. doi:10.1007/s11883-019-0791-9.